InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Tuesday, 12/10/2019 10:15:23 PM

Tuesday, December 10, 2019 10:15:23 PM

Post# of 180
News: $NVTA Invitae Announces Program with BioMarin to Expand Access to Genetic Testing for Skeletal Dysplasias

SAN FRANCISCO , Dec. 10, 2019 /PRNewswire/ --  Invitae (NYSE: NVTA), a leading medical genetics company, today announced the launch of Discover Dysplasias™ , an initiative with BioMarin Pharmaceutical to offer genetic testing at no charge to patients who show signs or symp...

Got this from NVTA - Invitae Announces Program with BioMarin to Expand Access to Genetic Testing for Skeletal Dysplasias
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.